Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:38 PM
Ignite Modification Date:
2025-12-24 @ 10:38 PM
NCT ID:
NCT00621335
Eligibility Criteria:
Inclusion Criteria:
* open angle glaucoma or ocular hypertension including pseudo-exfoliation and pigmentary glaucoma
* definitive glaucomatous optic disk cupping and/or glaucomatous visual field loss
* a stable treatment regime for at least 4 weeks prior to the study initiation, with a Cosopt mono or a Prostaglandin + Cosopt combination
* an IOP between 16 and 32 mmHg, with no readings above 35 mmHg at baseline
Exclusion Criteria:
* any other form of glaucoma other than primary open angle glaucoma
* a gonioscopy measured angle grade of less than 2
* a visual field defect not of glaucomatous origen
* previous history of cyclodestructive procedures
* the use of ocular non steroidal and anti-inflammatory topical agent that inhibit cyclooxygenase and prostaglandin analog synthesis
* the use of glucocorticoid therapy
* hypersensitivity to any of the study components
* any ocular laser therapy within the past three months
* ocular inflammation or infection in the past three months
* any history of trauma in the last six months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
90 Years
Study:
NCT00621335
Study Brief:
Protocol Section:
NCT00621335